Muath Bishawi
Areas of Research
Cardiovascular EngineeringBiography
Dr Muath Bishawi completed his BS in Biochemistry with honors, Masters of public health and evaluative sciences, and medical School with distinction at Stony Brook University in New York. He completed his cardiothoracic surgical residency and PhD in Biomedical Engineering at Duke University. His clinical expertise are in general adult cardiac surgery including coronary bypass and valvular surgery, with particular focus on heart and lung transplantation, mechanical support, and low ejection fraction complex adult cardiac procedures.
In addition to his clinical practice, Dr Bishawi has a dual appointment as assistant professor of Biomedical Engineering at Emory/Georgia Tech. He is deeply engaged in surgical research focused on device technologies, and basic and translational research in thoracic end stage disease and transplantation, securing funding from NIH, NASA, and industry. He has published over 100 peer reviewed manuscripts and has an H index of 27. He is a reviewer for multiple cardiac surgery journals, part of the editorial board for the Journal of Cardiac Failure, and an associate editor of the Journal of Cardiac Failure-Intersections. He has secured multiple patents, and launched a medical device company that successfully raised private equity funding and currently in the FDA regulatory process.
Education
- BS, Biochemistry and Cell Biology, Stony Brook University
- MPH, Evaluative Sciences , Stony Brook School of Medicine
- MD, Stony Brook School of Medicine
- PhD, Pratt School of Engineering, BME
Research Interests
My research focuses on advancing the treatment of advanced heart and lung disease through the integration of cardiac surgery, mechanical circulatory support, and translational bioengineering. I am particularly interested in developing and optimizing gene therapy strategies and device-based interventions to enhance myocardial recovery, improve transplant outcomes, and expand the donor organ pool. My laboratory integrates large-animal models, ex vivo perfusion systems, and molecular techniques to study cardiac remodeling, ischemia–reperfusion injury, and targeted viral vector delivery to the heart. By combining surgical innovation with genetic engineering and biomechanical design, our goal is to create clinically translatable solutions that improve durability, recovery, and long-term outcomes in patients with advanced cardiothoracic disease.
My lab is located in the Woodruff Memorial Research Building 5th floor.